Taggart v. Janssen Research & Development LLC et al

Filing 14

Conditional Transfer Order #1. Signed by MDL Panel on 12/23/2014. (Copies have been distributed pursuant to the NEF - SLR)

Case NV/2:14-cv-01963 Document 3 Filed 12/23/14 Page 1 of 3

UNITED STATES JUDICIAL PANEL
on
MULTIDISTRICT LITIGATION

IN RE: XARELTO (RIVAROXABAN)
PRODUCTS LIABILITY LITIGATION

MDL No. 2592

(SEE ATTACHED SCHEDULE)

CONDITIONAL TRANSFER ORDER (CTO −1)

On December 12, 2014, the Panel transferred 20 civil action(s) to the United States District Court
for the Eastern District of Louisiana for coordinated or consolidated pretrial proceedings pursuant to
28 U.S.C. § 1407. See _F.Supp.2d_ (J.P.M.L. 2014). Since that time, no additional action(s) have
been transferred to the Eastern District of Louisiana. With the consent of that court, all such actions
have been assigned to the Honorable Eldon E Fallon.
It appears that the action(s) on this conditional transfer order involve questions of fact that are
common to the actions previously transferred to the Eastern District of Louisiana and assigned to
Judge Fallon.
Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict
Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the
Eastern District of Louisiana for the reasons stated in the order of December 12, 2014, and, with the
consent of that court, assigned to the Honorable Eldon E Fallon.
This order does not become effective until it is filed in the Office of the Clerk of the United States
District Court for the Eastern District of Louisiana. The transmittal of this order to said Clerk shall
be stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the
Panel within this 7−day period, the stay will be continued until further order of the Panel.

FOR THE PANEL:

Dec 23, 2014
Jeffery N. Lüthi
Clerk of the Panel

Case NV/2:14-cv-01963 Document 3 Filed 12/23/14 Page 2 of 3

IN RE: XARELTO (RIVAROXABAN)
PRODUCTS LIABILITY LITIGATION

MDL No. 2592

SCHEDULE CTO−1 − TAG−ALONG ACTIONS

DIST

DIV.

C.A.NO.

CASE CAPTION

14−00522

Banks v. Janssen Research & Development LLC et al

ALABAMA SOUTHERN
ALS

1

CALIFORNIA CENTRAL
CAC

2

14−09056

Iris Crawford v. Janssen Research & Development, LLC
et al

CALIFORNIA NORTHERN
CAN

4

14−04972

Jonas v. Janssen Research & Development LLC et al

CALIFORNIA SOUTHERN
CAS
CAS

3
3

14−02523
14−02624

Tonyan v. Janssen Research & Development, LLC et al
Haney v. Bayer AG et al

1

14−03046

Harding et al v. Janssen Research & Development LLC

14−00655
14−01794

Lindsey v. Janssen Research & Development, LLC et al
Hoffman v. Bayer Healthcare Pharmaceuticals, Inc. et al

COLORADO
CO

FLORIDA MIDDLE
FLM
FLM

2
6

GEORGIA NORTHERN
GAN

3

14−00182

GAN

4

14−00267

Sinclair et al v. Janssen Research & Development, LLC
et al
West v. Janssen Pharmaceuticals, Inc. et al

14−08524

Van Dorn, Jr. v. Janssen Research & Development, LLC
et al

ILLINOIS NORTHERN
ILN

1

Case NV/2:14-cv-01963 Document 3 Filed 12/23/14 Page 3 of 3
ILLINOIS SOUTHERN
ILS
ILS
ILS
ILS
ILS
ILS

3
3
3
3
3
3

14−01236
14−01254
14−01271
14−01295
14−01299
14−01319

ILS

3

14−01332

Newman v. Janssen Research & Development LLC et al
Mize v. Janssen Research & Development LLC et al
Sandusky v. Janssen Research & Development LLC
Marrs v. Janssen Research & Development LLC et al
Moore v. Janssen Research & Development LLC et al
Danforth v. Janssen Research & Development LLC et al
Sokol et al v. Janssen Research & Development LLC et
al

14−00719

Dragg v. Janssen Research & Development LLC, et al

LOUISIANA MIDDLE
LAM

3

LOUISIANA WESTERN
LAW

1

14−03080

LAW

6

14−03046

Silvey et al v. Janssen Research & Development L L C
et al
St Amand et al v. Janssen Research & Development L L
C et al

2

14−01963

Taggart v. Janssen Research & Development LLC et al

14−00769

Mathena et al v. Janssen Research & Development LLC
et al

NEVADA
NV

OHIO SOUTHERN
OHS

1